Neurocrine Biosciences, Inc., is a leading neuroscience─focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator
Neurocrine Biosciences is a California-based biopharmaceutical company that develops therapeutics for the treatment of neurological and neuroendocrine disorders.